We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

146 hedge funds and large institutions have $806M invested in VanEck Pharmaceutical ETF in 2025 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 41 increasing their positions, 45 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 19

42% more call options, than puts

Call options by funds: $7.55M | Put options by funds: $5.33M

15% more funds holding

Funds holding: 127 → 146 (+19)

13% more capital invested

Capital invested by funds: $713M → $806M (+$93.1M)

9% less repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 45

45.98% less ownership

Funds ownership: 114.6% → 68.62% (-46%)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
146
Holders Change
+19
Holders Change %
+14.96%
% of All Funds
1.78%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
39
Increased
41
Reduced
45
Closed
19
Calls
$7.55M
Puts
$5.33M
Net Calls
+$2.22M
Net Calls Change
+$52.4M

Top Buyers

1
BCIM
British Columbia Investment Management
British Columbia, Canada
+$67M
2
Citigroup
Citigroup
New York
+$59.4M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$39.7M
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$18.6M
5
UBS Group
UBS Group
Switzerland
+$6.2M

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$105M
2
Morgan Stanley
Morgan Stanley
New York
-$36.8M
3
JP Morgan Chase
JP Morgan Chase
New York
-$24.7M
4
RAM
Revere Asset Management
Texas
-$15.6M
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$6.85M
Name Holding Trade Value Shares
Change 		Change in
Stake
CAL
126
Capital Analysts LLC
Pennsylvania
$24K – – –
GRP
127
Global Retirement Partners
California
$19.9K +$1.75K +18 +10%
AF
128
Advisornet Financial
Minnesota
$19.8K +$18.7K +192 New
NWM
129
Nova Wealth Management
Florida
$18.8K -$105K -1,084 -86%
OSAM
130
O'Shaughnessy Asset Management
Connecticut
$17.2K – – –
SIS
131
Sound Income Strategies
Florida
$15.1K +$13.9K +143 New
OP
132
ORG Partners
Indiana
$14.4K +$13.6K +140 New
TC
133
Trust Company
Kansas
$11.7K +$11K +113 New
NA
134
NewEdge Advisors
Louisiana
$10.4K -$97 -1 -1%
MA
135
MCF Advisors
Kentucky
$10.3K +$9.73K +100 New
TWC
136
TD Waterhouse Canada
Ontario, Canada
$10.3K -$6.81K -70 -41%
SWM
137
SHP Wealth Management
Massachusetts
$9.49K +$8.95K +92 New
AT
138
Arlington Trust
Alabama
$8.77K – – –
AWM
139
Activest Wealth Management
Florida
$7.63K – – –
AIM
140
Anchor Investment Management
South Carolina
$5.98K – – –
SEP
141
Signature Equity Partners
Ohio
$4.02K +$3.79K +39 New
SAG
142
SageView Advisory Group
California
$2.89K +$2.72K +28 New
TFA
143
Toth Financial Advisory
Virginia
$2.37K +$2.24K +23 New
AssetMark Inc
144
AssetMark Inc
California
$1.55K – – –
MSWM
145
Mowery & Schoenfeld Wealth Management
Illinois
$1.3K – – –
NFSG
146
Newbridge Financial Services Group
Florida
$1.14K +$1.07K +11 New
AF
147
Allworth Financial
California
$546 – – –
RAM
148
Revere Asset Management
Texas
– -$15.6M -172,958 Closed
Qube Research & Technologies (QRT)
149
Qube Research & Technologies (QRT)
United Kingdom
– -$6.85M -75,844 Closed
JGC
150
J. Goldman & Co
New York
– -$6.06M -67,015 Closed
3 4 5
6
7

PPH Hedge Fund Activity: Q4 2025 in Review

146 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q4 2025, worth a combined $806M — up 13% from $713M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new PPH positions and 19 closed out — a net gain of 20 holders — while 41 added to existing stakes and 45 trimmed.

The largest buyer was British Columbia Investment Management, opening a new position worth an estimated $67M. The largest seller was Goldman Sachs, cutting an estimated $105M.

  • 146 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q4 2025, up from 127 in Q3 2025.
  • Funds reported $806M of VanEck Pharmaceutical ETF stock for Q4 2025, up 13% quarter-over-quarter.
  • 39 funds opened new VanEck Pharmaceutical ETF positions in Q4 2025 and 19 closed out, a net change of +20 holders.
  • The largest VanEck Pharmaceutical ETF buyer in Q4 2025 was British Columbia Investment Management, an estimated $67M added.
  • The largest VanEck Pharmaceutical ETF seller in Q4 2025 was Goldman Sachs, an estimated $105M sold.

Based on aggregated 13F filings for Q4 2025.